I recently set up an account on the microblogging site https://t.co/VwA6W6bfqW and am looking for people to follow, especially in the #science and #medicine communities. Who here is on #Mastodon? If yes, drop your handle in the replies! You can find me @[email protected]
The published version of our study on the association between clonal hematopoiesis and Alzheimer's disease (AD) is now available. Thread below!
https://t.co/moYN57MfPj
Recurring somatic mutations are uncommon and inconsequential right? Nope!
Out today in @ScienceAdvances, our work led by @J__Stock disproves these widely held assumptions, discovering a new class of non-coding somatic mutations in blood with phenotypic impact. 🧵👇
Out in @Nature today, we describe a new method "PACER" to estimate clonal expansion rate and use it to identify that aberrant TCL1A activation as a cause of #CHIP expansion and potential therapeutic target @J__Stock @Jk_Gopakumar@jaiswalmdphd https://t.co/v32VoULUbB
Fatty liver dz is v common but our understanding of who progresses to inflammation & fibrosis is limited.
In @Nature, we discover clonal hematopoiesis as a modifiable risk factor for precision liver dz prevention.
https://t.co/kplZL8Zrjo @waihaywong@connoremdin B Ebert
[1/19]
Clonal hematopoiesis is an expansion of blood stem cell clones caused by mutations in a recurrent set of genes. Our paper on factors mediating expansion of these mutant clones is published today.
https://t.co/Q6NeqZz6sm
Thread below...
@RAMillager presented his recently published work on "Behavioral and cognitive-affective features of stuttering in preschool-age children" and won first prize!! 😍👏👏👏 Check out the publication here: https://t.co/1YwR8stwdD
Excited to share the last part of my PhD work, where we track co-receptor signaling dynamics during B cell activation! Great collaboration with @KalocsayMarian https://t.co/kYldzJb2Nk
Join us Tues 3/28 at 10am in 214 LH for Andrew Boal's @EyeBoal Dissertation Defense "Retinal Ganglion Cell Excitability and Adaptations to Ionic Stress in Glaucomatous Optic Neuropathy" completed in Dr. David Calkins lab in the Neuro Grad Program @VanderbiltBrain and @VUMCEye!
Thanks to the @AABB for highlighting our work on patient demographics in blood donation & transfusion clinical trials. We hope these findings will continue to drive conversations & actions on equitable representation. https://t.co/ToukDTwFS7